Breakthrough sepsis drug shows promise in human trial

Researchers at Griffith University report encouraging progress toward treating sepsis after a Phase II clinical trial in China produced positive results. The study suggests a new drug candidate may reduce the severity of sepsis, a condition that affects millions of hospitalized patients…

Click here to view the original article.